1. Omega-6 is not the enemy.
Omega-6 and omega-3 fatty acids are families of polyunsaturated fats with normal physiological roles. Linoleic acid and alpha-linolenic acid are essential because the body cannot synthesize them. The long-chain omega-3s EPA and DHA can come from food or supplements, while conversion from ALA is limited.
2. Modern diets create varied patterns.
US diets often contain abundant linoleic acid from vegetable oils while oily fish intake varies. That does not justify calling omega-6 toxic. A measured profile is more responsible than assuming every person shares the same imbalance.
3. A questionnaire is not a blood profile.
Food records estimate behavior and depend on recall, portions, recipes, and nutrient databases. A blood test measures selected fatty acids in a particular specimen using a particular method. Each answers a different question and has different sources of uncertainty.
4. Ratios simplify—and discard information.
A ratio can make a pattern easy to communicate, but two people can reach the same ratio with different numerator and denominator values. The BalanceTest’s published balance value is AA divided by EPA. It is one product-report marker, not a universal disease threshold.
5. EPA and DHA deserve separate attention.
EPA and DHA are distinct long-chain omega-3 fatty acids. Many status measures combine them; the complete report can preserve their separate percentages. The conventional Omega-3 Index is defined for EPA plus DHA in red-blood-cell membranes, so index-style values from other specimens should not be assumed equivalent.
6. Repeat measurement adds a time axis.
A baseline is descriptive. A same-method retest can document whether the selected markers changed after a defined interval. It remains an individual before-and-after comparison, not proof that one product caused every change or that a medical outcome occurred.
7. Dried blood spots are practical, not magic.
Peer-reviewed studies support fatty-acid analysis from dried blood spots and also identify method considerations: sample volume, collection material, extraction, calibration, and standardized reporting. Convenience does not make every laboratory or calculation interchangeable.
8. Polyphenols and oxidation need careful wording.
The official BalanceOil+ listing describes extra-virgin olive oil polyphenols and tocopherols in a fish-oil formulation. Oxidation is a legitimate formulation and storage issue, but this site does not extend that fact into unverified claims about absorption, cellular protection, or disease outcomes.
9. Evidence has boundaries.
Analytical validation shows whether a method measures consistently under defined conditions. It does not validate every interpretation layered onto a commercial report. Product pages verify current composition, offer structure, and the manufacturer’s stated framework; they are not independent trials.
10. The review standard
Scientific claims use peer-reviewed primary literature or government references. Product composition and workflow use current official US pages. Every page states whether a value is a measurement, a product-report target, or a marketing claim awaiting policy review.
References
- NIH Office of Dietary Supplements — Omega-3 Fatty Acids
- Ali et al. — n-3 index and AA/EPA ratio from dried blood spots
- Liu et al. — Quantitating fatty acids in dried blood spots
- Metherel et al. — Interlaboratory assessment of dried blood spot fatty acids
- Official US BalanceTest information
- Official US BalanceOil+ information
References checked July 21, 2026. The official product pages are used only for product composition, workflow, current availability, and report definitions. Independent medical review remains required before production.